Found: 100
Select item for more details and to access through your institution.
Publisher Correction: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
- Published in:
- Diabetologia, 2024, v. 67, n. 11, p. 2375, doi. 10.1007/s00125-024-06196-3
- By:
- Publication type:
- Article
Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
- Published in:
- Journal of Pathology, 2022, v. 257, n. 1, p. 82, doi. 10.1002/path.5871
- By:
- Publication type:
- Article
Cardiovascular Disease in Cirrhosis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 3, p. 655, doi. 10.1111/j.1572-0241.1999.00931.x
- By:
- Publication type:
- Article
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1172, doi. 10.3390/ijms24021172
- By:
- Publication type:
- Article
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8838, doi. 10.3390/ijms21228838
- By:
- Publication type:
- Article
Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 24, p. 6333, doi. 10.3390/ijms20246333
- By:
- Publication type:
- Article
Pathophysiology of Non Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 12, p. 2082, doi. 10.3390/ijms17122082
- By:
- Publication type:
- Article
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 5, p. 717, doi. 10.3390/ijms17050717
- By:
- Publication type:
- Article
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 479, doi. 10.3390/ijms17040479
- By:
- Publication type:
- Article
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 2, p. 320, doi. 10.1002/jmv.24954
- By:
- Publication type:
- Article
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3941, doi. 10.3390/jcm9123941
- By:
- Publication type:
- Article
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2353, doi. 10.3390/jcm9082353
- By:
- Publication type:
- Article
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1323, doi. 10.3390/jcm9051323
- By:
- Publication type:
- Article
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 3, p. 800, doi. 10.3390/jcm9030800
- By:
- Publication type:
- Article
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1646, doi. 10.3390/jcm8101646
- By:
- Publication type:
- Article
Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 267, doi. 10.3390/antibiotics13030267
- By:
- Publication type:
- Article
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 3, p. 155, doi. 10.3390/metabo11030155
- By:
- Publication type:
- Article
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1212, doi. 10.1111/apt.17941
- By:
- Publication type:
- Article
Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 249, doi. 10.1111/apt.17768
- By:
- Publication type:
- Article
Liver‐related and extrahepatic events in patients with non‐alcoholic fatty liver disease: a retrospective competing risks analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 604, doi. 10.1111/apt.16763
- By:
- Publication type:
- Article
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0299487
- By:
- Publication type:
- Article
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.
- Published in:
- Diabetologia, 2017, v. 60, n. 10, p. 1873, doi. 10.1007/s00125-017-4340-1
- By:
- Publication type:
- Article
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?
- Published in:
- Diabetologia, 2016, v. 59, n. 6, p. 1145, doi. 10.1007/s00125-016-3930-7
- By:
- Publication type:
- Article
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2016, p. 31421, doi. 10.1038/srep31421
- By:
- Publication type:
- Article
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and death.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2554, doi. 10.1111/dom.15615
- By:
- Publication type:
- Article
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087523
- By:
- Publication type:
- Article
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 6, p. 3498, doi. 10.1210/jc.2004-2240
- By:
- Publication type:
- Article
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 650, doi. 10.3390/jcm12020650
- By:
- Publication type:
- Article
Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5190, doi. 10.3390/jcm11175190
- By:
- Publication type:
- Article
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 635, doi. 10.3390/jcm11030635
- By:
- Publication type:
- Article
Efficacy of a Preparation Based on Calcium Butyrate, Bifidobacterium bifidum , Bifidobacterium lactis , and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4961, doi. 10.3390/jcm10214961
- By:
- Publication type:
- Article
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3387, doi. 10.3390/jcm10153387
- By:
- Publication type:
- Article
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3257, doi. 10.3390/jcm10153257
- By:
- Publication type:
- Article
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers.
- Published in:
- Panminerva Medica, 2022, v. 64, n. 4, p. 485, doi. 10.23736/S0031-0808.22.04590-6
- By:
- Publication type:
- Article
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1659, doi. 10.3390/cancers15061659
- By:
- Publication type:
- Article
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2305, doi. 10.3390/cancers13102305
- By:
- Publication type:
- Article
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3218, doi. 10.3390/cancers12113218
- By:
- Publication type:
- Article
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2776, doi. 10.3390/cancers12102776
- By:
- Publication type:
- Article
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1287, doi. 10.1001/jama.2024.1447
- By:
- Publication type:
- Article
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243590
- By:
- Publication type:
- Article
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2418, doi. 10.1111/liv.15377
- By:
- Publication type:
- Article
A cholestatic pattern predicts major liver‐related outcomes in patients with non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1037, doi. 10.1111/liv.15232
- By:
- Publication type:
- Article
Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1999, doi. 10.1111/liv.15013
- By:
- Publication type:
- Article
Natural history of NASH.
- Published in:
- Liver International, 2021, v. 41, p. 78, doi. 10.1111/liv.14910
- By:
- Publication type:
- Article
Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1227, doi. 10.1111/liv.14825
- By:
- Publication type:
- Article
Mechanisms for increased risk of diabetes in chronic liver diseases.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2489, doi. 10.1111/liv.14556
- By:
- Publication type:
- Article
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with non‐alcoholic fatty liver: An external validation study.
- Published in:
- Liver International, 2018, v. 38, n. 4, p. 715, doi. 10.1111/liv.13612
- By:
- Publication type:
- Article
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1389, doi. 10.1111/liv.13397
- By:
- Publication type:
- Article